Eagle Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $14.4M | Sell |
1,356,779
-580,930
| -30% | -$6.15M | 0.07% | 230 |
|
|
2024
Q2 | $15.6M | Buy |
1,937,709
+1,386,691
| +252% | +$11.2M | 0.08% | 213 |
|
|
2024
Q1 | $7.82M | Buy |
551,018
+100,562
| +22% | +$1.43M | 0.04% | 329 |
|
|
2023
Q4 | $3.66M | Buy |
+450,456
| New | +$3.66M | 0.02% | 409 |
|
|
2020
Q4 | – | Sell |
-63,874
| Closed | -$2.06M | – | 623 |
|
|
2020
Q3 | $2.06M | Sell |
63,874
-644,786
| -91% | -$20.8M | 0.01% | 442 |
|
|
2020
Q2 | $19.3M | Buy |
708,660
+275,325
| +64% | +$7.49M | 0.11% | 218 |
|
|
2020
Q1 | $13M | Buy |
433,335
+107,353
| +33% | +$3.21M | 0.08% | 243 |
|
|
2019
Q4 | $9.02M | Buy |
+325,982
| New | +$9.02M | 0.04% | 327 |
|